- Home
- PVL vs BDSX Comparison
PVL vs BDSX Comparison
Compare PVL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVL
- BDSX
- Stock Information
- Founded
- PVL 2011
- BDSX 2005
- Country
- PVL United States
- BDSX United States
- Employees
- PVL N/A
- BDSX N/A
- Industry
- PVL Oil & Gas Production
- BDSX Precision Instruments
- Sector
- PVL Energy
- BDSX Health Care
- Exchange
- PVL Nasdaq
- BDSX Nasdaq
- Market Cap
- PVL 59.7M
- BDSX 61.9M
- IPO Year
- PVL N/A
- BDSX 2020
- Fundamental
- Price
- PVL $1.77
- BDSX $7.36
- Analyst Decision
- PVL
- BDSX Strong Buy
- Analyst Count
- PVL 0
- BDSX 5
- Target Price
- PVL N/A
- BDSX $32.50
- AVG Volume (30 Days)
- PVL 79.7K
- BDSX 122.1K
- Earning Date
- PVL 01-01-0001
- BDSX 10-31-2025
- Dividend Yield
- PVL 10.88%
- BDSX N/A
- EPS Growth
- PVL N/A
- BDSX N/A
- EPS
- PVL 0.09
- BDSX N/A
- Revenue
- PVL $4,598,992.00
- BDSX $76,556,000.00
- Revenue This Year
- PVL N/A
- BDSX $18.80
- Revenue Next Year
- PVL N/A
- BDSX $27.76
- P/E Ratio
- PVL $19.03
- BDSX N/A
- Revenue Growth
- PVL 37.78
- BDSX 25.70
- 52 Week Low
- PVL $1.30
- BDSX $3.44
- 52 Week High
- PVL $2.04
- BDSX $34.40
- Technical
- Relative Strength Index (RSI)
- PVL 35.41
- BDSX 68.31
- Support Level
- PVL $1.81
- BDSX $7.36
- Resistance Level
- PVL $1.84
- BDSX $7.95
- Average True Range (ATR)
- PVL 0.06
- BDSX 0.58
- MACD
- PVL -0.02
- BDSX -0.16
- Stochastic Oscillator
- PVL 1.79
- BDSX 48.31
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.